作者
Bhushan M Kapur, Janine R Hutson, Tamanna Chibber, Adriana Luk, Peter Selby
发表日期
2011/8/1
来源
Critical reviews in clinical laboratory sciences
卷号
48
期号
4
页码范围
171-195
出版商
Taylor & Francis
简介
Numerous established and potential drug interactions with methadone are clinically important in people treated with methadone either for addiction or for chronic pain. Methadone users often have comorbidities and are prescribed drugs that may interact with methadone. Methadone is extensively metabolized by cytochrome P450 (CYP) 3A4 and to a lesser extent by CYP 1A2, 2D6, 2D8, 2C9/2C8, 2C19, and 2B6. Eighty-six percent of methadone is protein bound, predominately to α1 -acid glycoprotein (AGP). Polymorphisms in or interactions with CYPs that metabolize methadone, changes in protein binding, and other pathophysiological conditions affect the pharmacokinetic properties of methadone. It is critical for health care providers who treat patients on methadone to have adequate information on the interactions of methadone with other drugs of abuse and other medications. We set out to describe drug-drug …
引用总数
201020112012201320142015201620172018201920202021202220232024114918975117113633
学术搜索中的文章
BM Kapur, JR Hutson, T Chibber, A Luk, P Selby - Critical reviews in clinical laboratory sciences, 2011